Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Pages ix3, Published: 19 December 2015

Transcription

1 We Article use Navigation cookies to enhance your experience on our website. By clicking 'continue' or by continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Continue Find out more 10P Effect of pre-s2 mutation of hepatitis B virus subgenotype B3 the endemic strain in Indonesia on hepatocellular carcinoma: Observation on transcription factor NF-κB expression and activation M. Siburian, I. Suriapranata, S.I. Wanandi, G. Mathew Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Pages ix3, Published: 19 December 2015 Aim/Background: More than 50% of hepatocellular carcinoma (HCC) cases worldwide and 70-80% of HCC cases in highly hepatitis B virus (HBV) endemic regions are attributable to HBV. Indonesia has high prevalence of hepatitis B with subgenotype B3 as the major and endemic strain.cross sectional study on hepatitis B patients in Indonesia showed association of pre-s2 start codon mutation with severity liver disease which was dissimilar with studies from

2 other population where pre-s2 deletion mutation was more prevalent. The different mutation pattern was attributed to the different HBV subgenotype of each population study. HBV surface proteins were reported to induce the activation of NF-ĸB, a transcriptional factor known to involve directly in many aspects of chronic liver disease such as cirrhosis and HCC. Hence this study aimed to observe the effects of different HBs mutant variants of Hepatitis B Virus (HBV) subgenotype B3 as the endemic strain in Indonesia on the expression and activation of NF-ĸB. Methods: HBs genes of HBV subgenotype B3 isolated from three hepatitis B patients with HCCwere amplified and cloned to pcdna3.1, and were transfected using lipofectamine into Huh7 cell line. Expressions on mrna level for HBs, IĸB-α and NF-ĸB (p50) were evaluated using real-time PCR. IĸB-α expression which is regulated by NF-ĸB was used as parameter to measure NF-ĸB activation. Results: HBs mrna expressions were decreased after 48 to 72 hours. HBs protein expression detected using ELISA were increased at 72 hours for pre-s2 start codon mutation and pre-s2 deletion. NF-ĸB activation was higher for HBs wild type compared to the two mutant variants, however pre-s2 deletion mutant showed higher NF-ĸB activation after longer period of incubation. NFĸB (p50) expression was higher for pre-s2 start codon mutation. Conclusions: Pre-S2 mutations had no effect to the increment of NF-ĸB activation, however pre-s2 start codon mutation might associated to increased expression of NF-ĸB (p50).this suggests that pres2 start codon mutation and pre-s2 mutation may utilize different pathway in liver disease progression. Disclosure: All authors have declared no conflicts of interest. Topic: second heart sound, s2, mutation, carcinoma, hepatocellular, indonesia, hepatitis b virus, transcription factor

3 The Author Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please View Metrics alerts New issue alert Advance article alerts Article activity alert Receive exclusive offers and updates from Oxford Academic

4 More on this topic Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment Effect of functional nuclear factor-kappab genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma Population attributable fraction of infectionrelated cancers in Korea Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier Related articles in Google Scholar Citing articles via Google Scholar CrossRef Latest Most Read Most Cited Is there a future for EGFR Targeted Agents in Esophageal Cancer? Methylation in cell-free DNA for early cancer detection Alectinib versus chemotherapy in crizotinibpretreated anaplastic lymphoma kinase (ALK)

5 -positive non-small-cell lung cancer: results from the phase III ALUR study Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic? Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer About Annals of Oncology Editorial Board Author Guidelines Recommend to your Library Advertising and Corporate Services Journals Career Network Twitter Purchase Online ISSN

6 Print ISSN Copyright 2018 European Society for Medical Oncology About Us Contact Us Careers Help Access & Purchase Rights & Permissions Open Access Connect Join Our Mailing List OUPblog Twitter Facebook YouTube Tumblr Resources Authors Librarians Societies Sponsors & Advertisers Press & Media Agents Explore Shop OUP Academic Oxford Dictionaries Oxford Index Epigeum OUP Worldwide University of Oxford Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide Copyright 2018 Oxford University Press Cookie Policy Privacy Policy Legal Notice Site Map Accessibility Get Adobe Reader